Penn Center for Innovation

inventXYZ summer program will teach tech skills remotely via interactive digital projects

Posted on July 8, 2020 — Jessica Jones Gupta

The new education program from Nikil Ragav’s inventXYZ will allow students to learn key STEM skills from projects such as coding a COVID-19 simulator and building a Pong video game. Read more on Philly

High sensitivity tech offers a potential COVID-19 testing solution

Posted on July 6, 2020 — Jessica Jones Gupta

Dr. Ping Wang, an associate professor of pathology and laboratory medicine, investigates diagnostics and diagnostic technology at Penn. Her clinical work focuses on making sure diagnostic results are delivered accurately and in a timely manner for patients at the Hospital at the University of Pennsylvania. Her research interests align with that, focusing on developing novel diagnostic…

After saving his own life with a repurposed drug, a professor reviews every drug being tried against Covid-19. Here’s what he’s found

Posted on June 29, 2020 — Jessica Jones Gupta

The 35-year-old associate professor at the Penn Perelman School of Medicine leads the school’s Center for Cytokine Storm Treatment & Laboratory. For the last few years, he has dedicated his life to studying Castleman disease, a rare condition that nearly claimed his life. Against epic odds, he found a drug that saved his own life…

Linnaeus Therapeutics announces clinical trial collaboration agreement with Merck to evaluate LNS8801 in combination with KEYTRUDA

Posted on June 24, 2020 — Jessica Jones Gupta

Linnaeus Therapeutics, Inc., a privately held clinical-stage biopharmaceutical company focused on the development and commercialization of novel small molecule oncology therapeutics, today announced that it has entered into a clinical collaboration agreement with Merck to evaluate the combination of its lead investigational product candidate LNS8801, and Merck’s anti-PD-1 therapy, KEYTRUDA® (pembrolizumab) in patients with selected advanced solid…

The 10th annual Philly Tech Week will transform to all virtual

Posted on June 23, 2020 — Jessica Jones Gupta

Philly Tech Week is scheduled for September 21 to 25th.  This year, it will be 100% virtual with community events, the Dev conference, and a signature event.  Participants can expect to connect with some of the region’s most fascinating and edge-defining technologists, entrepreneurs, and future makers. Learn more. 

Philly Startup Leaders now has up to $550K committed to fund underrepresented founders

Posted on June 22, 2020 — Jessica Jones Gupta

Multiple funds and companies came together to provide hundreds of thousands of dollars in funding to support entrepreneurs from underrepresented backgrounds.  Philly Startup Leaders (PSL) received funding from GoPuff, Ben Franklin Technology Partners, and the city of Philadelphia. Read more on Philly

Linnaeus Therapeutics scientific cofounders publish preclinical pancreatic cancer data in cellular and molecular gastroenterology and hepatology

Posted on June 15, 2020 — Jessica Jones Gupta

Linnaeus Therapeutics, a privately held clinical-stage biopharmaceutical company focused on the development and commercialization of novel small molecule oncology therapeutics, announced that its scientific cofounders, Christopher Natale, PhD, Vice President of Research at Linnaeus and Todd Ridky, MD, PhD, Assistant Professor of Dermatology at the Perelman School of Medicine at the University of Pennsylvania, presented their findings…

Meet the 10 early-stage companies in Pennovation Accelerator’s 2020 cohort

Posted on — Jessica Jones Gupta

This year’s startups include two graduates of the Penn I-Corps program, Pawsitive and Percepta. Read more on Philly

Gene Therapy Program at Penn Medicine joins AAVCOVID Vaccine Project

Posted on May 31, 2020 — Jessica Jones Gupta

Renowned program led by James M. Wilson, MD, PhD, a leading expert in the technology platform used in the experimental vaccine, to conduct preclinical studies in joint research and development project with Massachusetts Eye and Ear and Massachusetts General Hospital. Read Penn Medicine News

Novartis inks deal to make experimental coronavirus vaccine

Posted on — Jessica Jones Gupta

Swiss drugmaker will make gene-based Covid-19 vaccine being developed at Massachusetts Eye and Ear, Massachusetts General Hospital and University of Pennsylvania. Read more in the Wall Street Journal